AI-generated summary
The authors report a pilot study testing photobiomodulation against sham irradiation for chemotherapy-induced palmo-plantar erythrodysesthesia, with blinded assessment after 2 weeks. They found a significant benefit from PBM compared with sham and pain reduction in 49% of patients, with no adverse reactions observed. The authors conclude PBM might be useful, but this is a pilot study.
- Who or what was studied
- Patients with chemotherapy-induced palmo-plantar erythrodysesthesia
- Limits stated in the abstract
- The abstract describes this as a pilot study and reports only a tentative conclusion, with no sample size stated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Low-level laser therapy, Laser, Sham, Pilot study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.